SBI Life Q1 FY27 Preview: Revenue, NBP, PAT Range

What is scheduled for July 24, 2026

SBI Life Insurance Company is in focus ahead of its Q1 FY27 earnings season, with the board of directors scheduled to meet on July 24, 2026 to consider and approve the audited financial results for the quarter ended June 30, 2026. Separately, market trackers also describe the Q1 FY27 results window as July or August 2026 (TBD), indicating that the exact results timing should be verified through exchange filings.

The preview is framed as an institutional-style forecast that tracks the company’s core operating levers such as new business premium, APE growth, VNB margin stability, and AUM. It also places SBI Life’s operating momentum against listed peers including HDFC Life, ICICI Prudential Life, and Max Financial, using the limited peer data points available.

Executive expectations flagged in the forecast material

The forecast content highlights an APE growth expectation of 12% to 15% YoY and expects VNB margin stability around 27.5%. These expectations matter because the market often reads life insurers through a combination of growth (premium and APE) and profitability (VNB and VNB margin), rather than only accounting revenue.

The same material also mentions an estimated Gross Written Premium (GWP) range of ₹14,500 crore to ₹15,200 crore. While GWP and APE are not interchangeable, the numbers provide a sense of the volume assumptions being used in the preview.

New business premium growth is the key near-term datapoint

SBI Life enters the quarter highlighted as the fastest-growing listed private insurer, supported by a 22.6% YoY jump in new business premium. The reported figure in the context is ₹8,905 crore, which is also described as tracking ahead of the company’s full-year guidance of about 14% APE growth.

The broader industry context is also constructive in the same dataset. In Q1 FY27, life insurance industry new business premium rose 16.6% to ₹1.09 lakh crore. Private insurers grew 27.5%, while LIC posted 10.3% growth. Within listed peers, SBI Life’s 22.6% growth is presented as a leadership datapoint.

A peer reference point is provided for ICICI Prudential Life Insurance, which recorded new business premium of ₹4,866 crore, up 21.3% YoY.

Revenue and PAT: forecast ranges versus the Q1 FY26 base

Estimates for SBI Life’s Q1 FY27 revenue are presented in multiple places and formats, but the key range is consistent: ₹48,012 crore to ₹54,077 crore. The year-on-year comparison base stated is Q1 FY26 revenue of ₹38,996 crore.

Profitability forecasts are also provided as a range. The preview expects PAT of ₹615 crore to ₹783 crore, versus ₹594 crore in Q1 FY26.

In addition to the range, a specific forecast is cited from Uniresearch: revenue of ₹50,539 crore and PAT of ₹699 crore. This is described as based on a 36-analyst consensus, applying +29.6% revenue growth and +17.7% profit growth to the verified Q1 FY26 base values.

Solvency and balance-sheet comfort indicators

The forecast content cites AUM of ₹4,30,000 crore and a solvency ratio range of 1.95x to 2.05x, compared with a stated regulatory requirement of 1.50x. Another solvency datapoint in the provided context is 1.96.

In the historical Q1 FY26 operational snapshot included in the dataset, SBI Life’s AUM is stated at ₹4.8 lakh crore, with 15% YoY growth, alongside an Indian Embedded Value (IEV) of ₹74,260 crore (20% YoY growth). These figures add context to the company’s scale and capital position going into FY27.

The transcript excerpt also notes there has been no fresh capital raised recently to strengthen solvency margin, and there were no immediate plans or announcements for new fundraising through debt or equity.

Operating metrics referenced from prior disclosures

A Q1 FY26 operational block in the provided text lists: PAT up 14% to ₹590 crore, VoNB up 12% to ₹1,090 crore, and VoNB margin at 27.4%. It also includes cost ratios such as total cost ratio 10.8%, commission ratio 4.4%, and operating expense ratio 6.3%.

Separately, a broader set of FY26 commentary mentions VoNB margin at 27.5% (and 29% excluding GST impact), and FY26 PAT of ₹2,470 crore (INR 24.7 billion) impacted by GST and Labour Code, with an adjusted PAT of ₹3,120 crore (INR 31.2 billion) excluding these impacts. These are not Q1 FY27 estimates, but they frame what “margin stability” is referring to in the preview language.

Stock context: CMP, valuation signal, and technical levels

The stock’s current market price (CMP) is cited as ₹1,790.9 on NSE (July 2026), with an additional reference point showing ₹1,884.8 (-1.40%) on Apr 22, 2026. A valuation snapshot in the dataset states the stock trades at a P/E of 75.7 with a market cap of ₹1,87,012 crore.

The technical setup described in the forecast material notes a “symmetrical pattern” between the 50-day and 200-day moving averages. It identifies an immediate resistance zone of ₹1,900 to ₹1,920 and support around ₹1,760 to ₹1,780.

A probability-based scenario table is also provided: base case 60%, optimistic 25%, pessimistic 15%. The same segment lists a 12-month target that appears in the transcript as ₹12,980 for the base case, ₹200 for the optimistic case, and ₹1,650 for the pessimistic case. Because these numbers are inconsistent with the nearby trading levels, readers should treat them as presented text from the source material and verify against the original slide.

Key numbers table

Market impact: what investors typically track from this setup

The combination of strong NBP growth (22.6% YoY) and a stated expectation of VNB margin stability around 27.5% sets the tone for the quarter. If the company sustains growth while holding margins, it tends to support confidence in embedded value compounding and future profit emergence, which is why APE and VNB are frequently emphasised in life insurance result previews.

At the same time, the dataset shows multiple moving parts that can influence quarterly optics, including product mix and market-linked policy demand. A separate historical note attributes margin support to lower demand for less profitable market-linked policies during periods of equity market volatility. Even without making a forward prediction, it helps explain why the preview focuses on margin stability rather than only growth.

Analysis: why the Q1 FY27 preview matters

Two datapoints dominate the near-term narrative in the provided material. First is SBI Life’s premium momentum, with ₹8,905 crore of new business premium and 22.6% YoY growth, positioned ahead of the company’s approximately 14% full-year APE growth guidance. Second is the earnings expectation set, with revenue projected in the ₹48,012 to ₹54,077 crore band and PAT projected at ₹615 to ₹783 crore, giving markets a numeric framework before the board meeting.

The peer and industry context strengthens interpretation. Industry NBP growth of 16.6% and private insurers at 27.5% provides a sector tailwind reference point, while ICICI Prudential Life’s 21.3% NBP growth offers a direct listed-peer comparison. For investors, the key question is less about one quarter’s accounting outcome and more about whether SBI Life sustains its relative growth position while staying within its stated profitability band.

Conclusion

SBI Life’s Q1 FY27 setup combines strong new business premium growth with forecasts that focus on revenue and PAT ranges and stable VNB margins. The next hard catalyst is the July 24, 2026 board meeting scheduled to consider and approve the audited results for the quarter ended June 30, 2026, with the exact results timing to be confirmed via NSE and BSE filings.